(C) Estimated IC50 and its uncertainty for skin cutaneous melanoma cell lines tested with the immunomodulatory drug lenalidomide, which showed significant association with KRAS copy number alteration in the ANOVA test. Here, KRAS is linked to cutaneous melanoma.